Drug Database
Back to search

Poland· PL-100423306

Sirdalud

A tizanidine product containing tizanidinum, registered in Poland by PharmaVitae Sp. z o.o. sp. k.. The same ATC class is registered in 14 of our 19 countries.

ATC M03BX02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSirdaludATCM03BX02REGISTER NO.PL-100423306PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tizanidinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tizanidine is registered in 14 of 19 countries.

Countries holding a registration under ATC M03BX02 (tizanidine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search tizanidine products by name

Tizanidine · ATC M03BX02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tizanidine costs, country by country.

Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tizanidine · price per daily dose (12 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.38
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Tizanidinum
Manufacturer
PharmaVitae Sp. z o.o. sp. k.
Country
Poland (PL)
ATC code
M03BX02
ATC class
Tizanidine
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991410636
  • gtin
    05909991410643

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

384 interactions on record for tizanidine.

Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tizanidine against other medicinesHow interaction checks work

Tizanidine · interactions on record

384 records

  • 78 severe
  • 177 moderate
  • 2 minor
  • 87 info

Most severe, free to view

  • CimetidineA02BA01severe
  • FamotidineA02BA03severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe

40 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tizanidine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tizanidine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Sirdalud, Sirdalud Mr
  • Belgium · Sirdalud
  • Bulgaria · Tizanidine Teva, Тизанидин Tева
  • Czechia · Sirdalud
  • Germany · Sirdalud, Tizanidin Ascend
  • Denmark · Sirdalud Retard, Tizanidin Teva
  • Estonia · Sirdalud
  • Spain · Sirdalud
  • Finland · Sirdalud, Sirdalud Retard
  • United Kingdom (Northern Ireland) · Tizagelan, Tizanidine
  • Greece · Sirdalud
  • Croatia · Tizanidin Altamedics
  • Hungary · Sirdalud, Sirdalud Mr
  • Ireland · Tizanidine Teva
  • Italy · Navizan, Sirdalud
  • Lithuania · Sirdalud
  • Luxembourg · Sirdalud
  • Latvia · Sirdalud
  • Netherlands · Chordyna, Sirdalud
  • Portugal · Sirdalud, Tizanidina Teva
  • Slovenia · Sirdalud
  • Slovakia · Sirdalud

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/feb5d302-2db8-49cc-9312-d26dec8c4f69
GET /v1/drugs/feb5d302-2db8-49cc-9312-d26dec8c4f69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "4 mg",
  "packaging": "05909991410636 ¦ Rp ¦ 133549\n10 tabl.\n05909991410643 ¦ Rp ¦ 133550\n30 tabl.",
  "substance": "Tizanidinum 4 mg",
  "common_name": "Tizanidinum",
  "pl_product_id": "100423306",
  "pozwolenie_nr": "260/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-07-16"
}
API referenceMCP serverPlans

See everything about tizanidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console